PB 81 of 2020

National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2020 (No. 7)

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, and delegate of the Minister for Health make the following determination.

Dated    26 August 2020

THEA DANIEL  

Contents

1 Name

2 Commencement

3 Authority

4  Schedule

Schedule 1—Amendments 2

National Health (Continued Dispensing - Emergency Measures) Determination 2020 2

1  Name

(1)  This instrument is the National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2020 (No. 7).

(2)  This instrument may also be cited as PB 81 of 2020.

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

  This instrument is made under subsection 89A(3) of the National Health Act 1953.

4  Schedules

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Continued Dispensing – Emergency Measures) Determination 2020

[1]           Schedule 1, after entry for Abiraterone in the form Tablet containing abiraterone acetate 500 mg

insert:

[2]           Schedule 1, after entry for Imipramine in the form Tablet containing imipramine hydrochloride 25 mg

insert:

[3]           Schedule 1, after entry for Methylphenidate in the form Capsule containing methylphenidate hydrochloride 40 mg (modified release)

insert: